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Prevalence and clinical significance of childhood 
and adolescent depression
Major  depressive  disorder  (MDD)  during  childhood  is 
relatively  uncommon  and  the  12-month  prevalence 
ranges from 0.5% to 3% [1,2], with an equal proportion of 
girls and boys affected or a slight preponderance of boys. 
Adolescence  is  a  period  of  vulnerability  for  depressive 
disorder  with  first  onsets  often  occurring  during  this 
period and subthreshold symptoms increasing markedly 
[3-5]. Estimates of the 12-month prevalence of depressive 
disorder in adolescence range from 2% to 8%, and the 
figure for lifetime adolescent depression is 20% [1,2,6]. In 
adolescence, the ratio of affected females to males is 2:1, 
which  mirrors  the  pattern  seen  in  adult  life  [2,6]. 
Adolescent subthreshold symptoms are not benign, and 
high  levels  of  depressive  symptoms  that  fall  below  the 
diagnostic  threshold  are  associated  with  functional 
impairment [7]. Depression interferes with the ability of 
young  people  to  meet  their  academic,  economic  and 
social potential, and is associated with a greatly increased 
risk of suicide and suicidal behaviour [1]. A significant 
proportion  of  depressed  adolescents  continue  to  have 
mental  health  problems  and  poor  social  outcomes  in 
adult life [8].
Features of childhood/adolescent depression 
compared with adult depression
The criteria used to diagnose depression in children and 
adolescents are the same as those used in adults, with the 
only exception being that the Diagnostic and Statistical 
Manual of Mental Disorders criteria allow irritable mood 
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children  and  adolescents  [9].  The  fact  that  the  same 
criteria  are  used  to  diagnose  depression  in  childhood/
adolescence and adulthood implicitly assumes similarity 
in the presentation of depression across developmental 
stages.  Although  very  few  studies  have  compared  the 
phenomenology  or  symptom  profiles  of  childhood/
adolescent  depression  with  that  of  adult  depression, 
evidence  suggests  that  there  may  be  heterogeneity 
between childhood/adolescent and adult depression, and 
also between depression in childhood and adolescence. 
This evidence comes from epidemiological studies that 
compare risk factors for childhood/adolescent and adult 
depression,  as  well  as  from  studies  examining  rates  of 
familial  aggregation  and  continuity  of  childhood  and 
adolescent depression.
One epidemiological study used a prospective design 
and  showed  that  risk  factors  for  depression  in  young 
people differ from those for depression in adult life [10]. 
Jaffee  and  colleagues  assessed  a  range  of  putative  risk 
factors for depression in childhood (occurring prior to 
the age of 9 years) [10]. The cohort was then assessed for 
MDD  on  six  occasions  between  childhood  and  adult-
hood. The authors were therefore able to compare four 
groups of individuals: (1) those with no MDD; (2) those 
with MDD in childhood/adolescence only; (3) those with 
MDD  in  childhood/adolescence  that  recurred  in  adult 
life; and (4) those with MDD in adult life only. Individuals 
with an onset of depression in adulthood had a similar 
risk profile to those without a history of depression, with 
the exception of higher rates of sexual abuse (which was 
the  only  risk  factor  assessed  retrospectively  in  adult-
hood). In contrast, individuals with depressive episodes 
in childhood/adolescence showed elevated rates of a range 
of  childhood  risk  factors,  including  perinatal  insults, 
parental  psychopathology,  motor  skill  deficits  and  care-
taker  instability.  Therefore,  this  finding  points  to  the 
likelihood of etiological heterogeneity between childhood/
adolescent  and  adult  depression.  This  requires  further 
investi  gation in additional studies using prospective designs.
Long-term  clinical  follow-up  studies  and  epidemio-
logical  studies  show  that  there  is  strong  homotypic 
continuity  between  adolescent  and  adult  depression. 
Thus, both adolescent depressive symptoms and disorder 
predict  episodes  of  depression  in  adult  life  [11-13]. 
Evidence of the continuity of childhood depression with 
adult depression is not as strong, and two independent 
follow-up studies of clinic-referred prepubertal depressed 
patients report low rates of homotypic continuity with 
depression  in  adulthood  [14,15],  and  instead  report 
heterotypic continuity where childhood depression cases 
show  increased  rates  of  other  problems  in  adult  life, 
including conduct disorder. Thus, prepubertal depression 
differs  from  postpubertal  depression  in  terms  of 
continuity  with  adult  MDD.  A  prospective  community 
study  has  reported  that  recurrence  in  early  adult  life 
could  be  a  marker  for  etiological  heterogeneity  in 
childhood/adolescent depression [10]. That study found 
that  childhood/adolescent  MDD  that  did  not  recur  in 
early  adult  life  was  characterized  by  a  male  prepon-
derance  and  comorbidity  with  externalizing  disorders, 
whereas childhood/adolescent MDD with recurrence in 
early  adult  life  was  characterized  by  a  female  prepon-
derance  and  comorbidity  with  anxiety  disorders  [10]. 
This issue of etiological heterogeneity between childhood 
and  adolescent  depression  has  also  been  examined  by 
family studies, as reviewed below.
Genetic factors associated with childhood and 
adolescent depression
Family studies
Family studies cannot disentangle similarity that is due to 
genetic factors from that due to environmental factors. 
However,  they  are  an  important  first  step  in  genetic 
epidemiology studies as they provide an upper limit to 
heritability  estimates.  They  also  provide  information 
about the conditions under which familial aggregation is 
greatest, and this is useful for genomic studies. Family 
studies  of  MDD  in  young  people  have  used  two 
approaches: ‘bottom-up studies’ examining the relatives 
of  depressed  children/adolescents,  and  ‘top-down 
studies’ focused on the offspring of depressed parents. 
All  studies  have  patterns  of  strength  and  weakness; 
however,  it  is  worth  noting  that  these  may  differ  for 
bottom-up and top-down studies. In particular, clinical 
referral biases may be important to consider in bottom-
up studies, as very high proportions of depressed children/
adolescents never present at clinic [16], while top-down 
studies may show higher rates of aggregation than bottom-
up  studies  given  that  depression  in  a  parent  adversely 
affects the family environment [17]. Studies of children/
adolescents with MDD generally report a twofold increase 
in  risk  to  first-degree  relatives  compared  with  healthy 
control groups. The offspring of depressed parents show a 
three- to fourfold increase in risk for MDD compared with 
the offspring of healthy control groups [18]. The prognosis 
of depression (if it develops) may also be particularly poor 
in these high-risk offspring [19].
One issue pertinent to genetic studies of depression has 
arisen from family studies using retrospective methods to 
date the onset of the disorder. Several such family studies 
report that MDD with an onset in early adult life (onset 
before age 20 or 30 years) shows higher levels of familial 
aggregation than depression with a later onset [20,21]. 
This finding has been extrapolated, and it has led some 
researchers to suggest that childhood-onset MDD cases 
should  be  the  focus  of  molecular  genetic  studies  [22]. 
However,  it  is  important  to  bear  in  mind  that  familial 
Rice Genome Medicine 2010, 2:68 
http://genomemedicine.com/content/2/9/68
Page 2 of 6loading can be due to both genetic and environmental 
factors.  Moreover,  this  pattern  of  results  has  not  been 
confirmed  in  studies  using  prospective  measures  and 
those  examining  familial  aggregation  of  childhood  and 
adolescent onset MDD. Methodological issues relating to 
retrospective recall mean that prospective methods are 
preferable for assessing the timing of onset of depressive 
episodes [23,24]. Indeed, the only study that has directly 
compared the familiality of prepubertal, postpubertal and 
adult-onset depression found remarkably little difference 
among  the  rates  of  familial  aggregation  of  depression 
[25], and the pattern of results suggested that prepubertal 
depression was slightly less familial than either adolescent 
or adult-onset depression. Furthermore, the two studies 
that  have  examined  the  continuity  of  prepubertal  and 
postpubertal  depression  with  depression  in  adult  life 
both report low rates of homotypic continuity of child-
hood  MDD  compared  with  adolescent  MDD  with 
depres  sion in adult life [14,15]; this highlights potential 
differences between childhood and both adolescent and 
adult depression. Weissman and colleagues [15,26] have 
suggested  that  there  may  be  subdivisions  within 
childhood-onset  MDD;  specifically,  that  there  is  a 
subtype of familial recurrent childhood MDD. However, 
given  that  so  few  family  studies  have  distinguished 
between childhood- and adolescent-onset MDD, and that 
retrospective  and  prospective  family  studies  report 
different results, this requires investigation in prospective 
studies that examine recurrence and continuity. Results 
of the studies suggesting differences between childhood/
adolescent depression that occurs only in early life and 
that which recurs in adult life [10,26] have an important 
implication  for  molecular  genetic  studies  of  MDD: 
namely, that if recurrence does index a form of childhood 
MDD that is familial, genetic studies using a ‘follow-back’ 
approach  that  includes  depressed  adults  who  retro-
spectively report that their first onset was in childhood/
adolescence  (that  is,  those  with  early-onset  MDD  that 
recurs in adult life) will not necessarily yield the same 
results  as  genetic  studies  that  include  childhood/
adolescent depressed probands [26].
Twin studies
Twin studies of children and adolescents have been used 
to examine the extent to which variation in depressive 
symptoms are due to genetic or environmental factors. A 
range  of  approaches  looking  at  adopted  children  or 
children of twins have been used to assess the relative 
impact of genes and environment to transmission within 
families. In the classic twin design, which includes pairs 
of identical (monozygotic) and fraternal (dizygotic) twins 
reared  together,  the  heritability  estimate  refers  to  the 
proportion of variation in a phenotype that is attributable 
to genetic factors. The fact that monozygotic twins share 
all  their  genes  in  common  and,  on  average,  dizygotic 
twins  share  50%  of  their  genes  in  common  provides  a 
‘natural experiment’ that allows the heritability estimate 
to be statistically inferred and the remaining proportions 
of variation are attributed to environmental influences. 
Environmental  influences  are  usually  subdivided  into 
shared  environmental  (that  is,  influences  that  tend  to 
make twin pairs more similar) and non-shared or unique 
(that is, influences that impinge uniquely on one twin and 
tend  to  make  twin  pairs  dissimilar).  The  heritability 
estimate is a statistic that includes the effect of all genes, 
as  well  as  indirect  genetic  influences  such  as  gene-
environ  ment  correlation  and  gene-environment  inter-
action. Twin studies of depressive symptoms in children 
and adolescents have shown that depressive symptoms in 
young  people  are  heritable.  However,  there  is  marked 
variation in heritability estimates across different studies 
[18,27]. Some variability is expected because heritability 
estimates  are  population-based  statistics;  however,  the 
magnitude  of  heritability  estimates  appears  to  differ 
according to who reports on the symptoms of the child 
(child,  parent,  teacher),  meaning  that  firm  conclusions 
are  difficult  to  establish.  This  issue  requires  further 
investi  gation as it has implications for refining the pheno-
type  for  molecular  genetic  studies.  One  consistent 
finding from twin studies is that the influence of genetic 
factors  on  depression  is  small  and  non-significant  in 
childhood  and  increases  in  adolescence  [28-31].  One 
twin  study  reports  that  this  age-related  difference  in 
genetic  etiology  of  depression  between  childhood  and 
adolescence  may  be  partly  due  to  gene-environment 
correlation,  which  increases  around  adolescence  as 
young people have greater independence in selecting and 
shaping  environments  at  this  time  [32].  Longitudinal 
studies also report that ‘new’ genetic influences emerge 
in adolescence [31], although no longitudinal study has 
specifically  focused  on  the  childhood-to-adolescence 
transi  tion.  There  has  been  only  one  twin  study  of 
adolescent  depressive  disorder  (in  females  aged  12  to 
23 years, mean age at assessment 15 years) [23], and this 
reported a heritability estimate of 40% (95% confidence 
interval, 24 to 55), which is consistent with results from a 
meta-analysis  of  adult  twin  studies  that  reported  a 
heritability estimate of 37% (95% confidence interval, 31 
to 42) for MDD [33]. Thus, evidence to date suggests that 
genetic influences on risk for adolescent major depression 
are  moderate,  and  account  for  around  40%  of  the 
phenotypic variation; for symptoms the figure is between 
30% and 50%, but for depressive symptoms in childhood 
the figure is much smaller and non-significant [18]. One 
final  group  of  relevant  findings  from  twin  studies  are 
those from studies examining the etiology of high levels 
of  depressive  symptoms  in  children  and  adolescents 
(instead  of  depressive  disorder).  Here,  the  evidence  is 
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than depressive symptoms within the normal range. This 
surprising  finding  was  evaluated  by  Glowinski  and 
colleagues  [23]  when  they  compared  heritability  esti-
mates for a broad phenotype of sadness and/or anhedonia 
lasting 2 weeks with that of a diagnosis of MDD. They 
found that the broader phenotype was largely influenced 
by shared environmental influences, whereas a diagnosis 
of MDD depended on both heritable and environmental 
factors.  This  illustrates  the  importance  of  precision  in 
diagnostic definitions for molecular genetic studies: for 
instance, on the basis of current evidence, it would seem 
inappropriate  to  focus  gene-finding  studies  on  adoles-
cents with high levels of symptoms.
Adoption studies
There  have  been  three  adoption  studies  that  have 
examined depression-related phenotypes in children and 
adolescents  (two  examined  internalizing  problems 
(depres  sion, anxiety and withdrawal) and one examined 
MDD) [34-36]. Interestingly, all of the adoption studies 
have found little evidence for genetic transmission of risk 
for  depression.  The  most  recent  study  by  Tully  and 
colleagues  [36]  examined  similarity  between  adoptive 
(unrelated) parents and adolescents for lifetime MDD, as 
well  as  a  control  sample  of  non-adopted  children  and 
their  biological  parents.  Adoptive  adolescents  whose 
unrelated parents had experienced lifetime MDD showed 
elevated  rates  of  depression  compared  with  adopted 
children  whose  unrelated  parents  had  not  had  MDD 
(odds  ratio,  2.19).  That  pattern  of  results  is  consistent 
with an important shared environmental component to 
the  intergenerational  transmission  of  depression. 
Inherited influences did make some contribution, as the 
same  comparison  in  the  biologically  related  group 
resulted in a slightly, though not significantly, higher risk 
(odds ratio, 2.96). Ongoing research is examining genetic 
and  environmental  contributions  to  the  parent-child 
transmission  of  depression  using  alternative  research 
designs, such as the children of twins design [37] and an 
in  vitro  fertilization  design  [38],  and  reports  evidence 
consistent  with  environmental  transmission  of  depres-
sion between parents and children [39].
Molecular genetic studies of childhood/adolescent 
depression
Molecular  genetic  studies  of  childhood/adolescent 
depres  sion  are  in  their  infancy  and  have  tended  to  be 
guided by results from studies of adult depression. These 
studies have tended to use a candidate gene approach and 
focus on functional polymorphisms in genes involved in 
pathways thought to be important in depression, includ-
ing  stress  response  and  hypothalamic-pituitary-adrenal 
axis  functioning.  There  are  a  small  number  of 
genetic-association  studies  of  childhood/adolescent 
MDD  that  rely  on  small  sample  sizes.  A  number  of 
studies have examined putative gene-environment inter-
actions  with  childhood/adolescent  MDD,  where  genes 
influence outcome by modulating response to environ-
mental risk [40]. Pharmacogenetic studies of adolescent 
depression  have  recently  begun,  following  reports  of 
genetic  variation  influencing  treatment  responses  to 
antidepressants in adults [41].
Some  studies  of  childhood/adolescent  depressive 
symp  toms and MDD have focused on a variable nucleo-
tide tandem repeat in the serotonin transporter gene. The 
serotonin  transporter  removes  serotonin  released  into 
the synaptic cleft and is a key regulator of serotonergic 
neurotransmission. A repeat-length polymorphism in the 
promoter of this gene has been shown to affect the rate of 
serotonin uptake, with the short variant reducing sero-
tonin transporter expression, resulting in higher concen-
trations of serotonin in the synaptic cleft compared with 
the  long  variant  [42].  However,  it  should  be  borne  in 
mind that there are low- and high-functioning forms of 
the  long  variant,  meaning  that  the  polymorphism  is 
functionally  tri-allelic  [43].  In  adults,  the  short  variant 
has been associated with neuroticism and anxiety-related 
traits [42], an elevated cortisol response to stress [44], 
greater amygdala activity when viewing fearful emotional 
faces [45] and with depression when in combination with 
life stress [46]. Converging evidence from various sources 
therefore  suggests  that  this  polymorphism  may  be 
involved in reactivity to stress, although there are also 
non-replications  [47-49].  In  children/adolescents,  one 
small study has reported significant association between 
the  short  variant  and  depression  using  a  case-control 
design  and  a  family-based  association  design  [50]. 
However, the short variant has also been associated with 
childhood  aggression  as  opposed  to  depression  [51]. 
There  are  a  number  of  gene-environment  interaction 
studies  where  the  effect  of  the  short  variant  in 
combination with stress has been examined. One study 
reported that the short variant was associated with high 
levels of depressive symptoms in female adolescents in 
combination with life stressors [52], although there has 
been a non-replication in a large sample of prepubertal 
children  using  a  measure  of  emotional  problems  [53]. 
Other studies have examined different measures of life 
stress and reported that the short variant modifies the 
effect  of  stress  on  depression  symptom  scores  in 
adolescents [54]. Moreover, there have been reports of 
gene-by-gene-by-environment  interactions  with 
childhood  maltreatment  as  the  environmental  factor 
[55]. Specifically, an interaction between the short variant 
of  the  serotonin  transporter  and  the  Val66Met 
polymorphism  in  the  gene  encoding  brain-derived 
neurotrophic factor has been reported to be associated 
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children,  but  not  in  a  healthy  control  group  [55]. 
Goodyer and colleagues [56] examined the relationship 
between  the  serotonin  transporter  polymorphism, 
cortisol  res  ponse  and  MDD  in  a  12-month  follow-up 
study  of  400  adolescents  selected  for  high  levels  of 
adversity.  The  authors  showed  that  possession  of  the 
short  variant  was  associated  with  higher  morning 
cortisol  levels  and  that  the  combination  of  higher 
cortisol  levels  and  the  short  variant  predicted  an 
episode of depressive disorder at 12-month follow-up in 
both males and females.
Finally,  two  small  pharmacogenetic  studies  have 
reported genetic influences on poor treatment outcome 
in adolescent depression [57,58]. The first study reported 
lower efficacy of citalopram and higher suicidality scores 
for adolescents homozygous for the short variant of the 
serotonin  transporter  gene  [57].  The  second  study 
examined  antidepressant  response  in  adolescents  un-
responsive  to  a  selective  serotonin  reuptake  inhibitor, 
and  reported  that  genotypes  in  FKBP5,  a  gene  that 
encodes  a  protein  causing  subsensitivity  of  the  gluco-
corticoid receptor, are associated with suicidal events and 
behaviour [58,59].
Conclusions
Molecular  genetic  studies  of  childhood  and  adolescent 
depression are only just beginning and tend to include 
small  samples.  There  are  complex  issues  regarding 
phenotypic definition and heterogeneity that need to be 
addressed  before  molecular  genetic  studies  begin  in 
earnest. Longitudinal studies of community and high-risk 
groups  will  help  to  establish  which  definitions  of 
childhood/adolescent depression yield the highest rates 
of familial aggregation, although it is clear that there are 
substantial  environmental  influences  on  depression  in 
young  people,  particularly  when  intergenerational 
transmission between parents and children is examined. 
As well as influencing biological processes, genetic influ-
ences on depression may be indirect and affect disorder 
through  influences  on  behaviour  (gene-environment 
correlation)  and  susceptibility  to  environmental  risk 
(gene-environment  interaction).  Research  examining 
cognitive-affective  processing  -  for  instance,  through 
functional brain imaging and neurocognitive approaches - 
may be useful in elucidating the complex pathways from 
risk  factor  (genetic  or  environmental)  to  disorder. 
Observations  from  genetic  epidemiology  show  that 
particular definitions of depression in childhood/adoles-
cence (childhood symptoms, high levels of symptoms in 
childhood and adolescence) are not significantly heritable 
and this means that genomic approaches are premature 
until further work has been done on refining phenotypic 
definitions for genetic studies.
Abbreviation
MDD, major depressive disorder.
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